StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd. (ONC) stock

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/302571% above fair value
$413.26+1.97 (+0.48%)

Close on Nov 17, 2026Market cap $46.99BP/E 73.9Yield –

BeOne Medicines price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

BeOne Medicines's price to book ratio was 9.2× on Nov 11, 2026, against 9.1× a year earlier. Over the last 5 years it ranged from 2.4× to 9.9×, with a median of 6.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20269.2×+1.0
2025Dec 31, 20258.1×+2.4
2024Dec 31, 20245.7×+0.7
2023Dec 29, 20235.0×+0.1
2022Dec 30, 20224.9×−2.6
2021Dec 31, 20217.5×+2.0
2020Dec 31, 20205.5×+4.7
2019Dec 31, 20190.8×−3.4
2018Dec 31, 20184.2×−1.7
2017Dec 29, 20175.9×+0.6
2016Dec 30, 20165.3×–

More BeOne Medicines figures

See a number that looks wrong?